{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:55:24Z","timestamp":1794340524924,"version":"4.9.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Doctoral Start-up Foundation of Yichang Central People\u2019s Hospital","award":["2024BS004385"],"award-info":[{"award-number":["2024BS004385"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-57693-x","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:16:54Z","timestamp":1781633814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A 5mC-related gene signature predicts prognosis and therapy response in hepatocellular carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Shaohua","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedong","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"3","key":"57693_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74 (3), 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"57693_CR2","doi-asserted-by":"publisher","first-page":"188314","DOI":"10.1016\/j.bbcan.2019.188314","volume":"1873","author":"D Anwanwan","year":"2020","unstructured":"Anwanwan, D., Singh, S. K., Singh, S., Saikam, V. & Singh, R. Challenges in liver cancer and possible treatment approaches. Biochim. Biophys. Acta Rev. Cancer. 1873 (1), 188314 (2020).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"6","key":"57693_CR3","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.jhep.2022.01.014","volume":"76","author":"J Calderaro","year":"2022","unstructured":"Calderaro, J., Seraphin, T. P., Luedde, T. & Simon, T. G. Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma. J. Hepatol. 76 (6), 1348\u20131361 (2022).","journal-title":"J. Hepatol."},{"issue":"10","key":"57693_CR4","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","volume":"20","author":"MVC Greenberg","year":"2019","unstructured":"Greenberg, M. V. C. & Bourc\u2019his, D. The diverse roles of DNA methylation in mammalian development and disease. Nat. Rev. Mol. Cell. Biol. 20 (10), 590\u2013607 (2019).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"1","key":"57693_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40246-020-00265-5","volume":"14","author":"T Xu","year":"2020","unstructured":"Xu, T. & Gao, H. Hydroxymethylation and tumors: can 5-hydroxymethylation be used as a marker for tumor diagnosis and treatment? Hum. Genomics. 14 (1), 15 (2020).","journal-title":"Hum. Genomics"},{"key":"57693_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pharmthera.2017.11.002","volume":"184","author":"GD Ginder","year":"2018","unstructured":"Ginder, G. D. & Williams, D. C. Jr. Readers of DNA methylation, the MBD family as potential therapeutic targets. Pharmacol. Ther. 184, 98\u2013111 (2018).","journal-title":"Pharmacol. Ther."},{"issue":"9","key":"57693_CR7","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrg.2017.33","volume":"18","author":"X Wu","year":"2017","unstructured":"Wu, X. & Zhang, Y. TET-mediated active DNA demethylation: mechanism, function and beyond. Nat. Rev. Genet. 18 (9), 517\u2013534 (2017).","journal-title":"Nat. Rev. Genet."},{"issue":"5929","key":"57693_CR8","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324 (5929), 930\u2013935 (2009).","journal-title":"Science"},{"issue":"1","key":"57693_CR9","first-page":"65","volume":"20","author":"BK Oh","year":"2007","unstructured":"Oh, B. K. et al. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Int. J. Mol. Med. 20 (1), 65\u201373 (2007).","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"57693_CR10","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/hep.30146","volume":"69","author":"J Liu","year":"2019","unstructured":"Liu, J. et al. Global DNA 5-Hydroxymethylcytosine and 5-Formylcytosine Contents Are Decreased in the Early Stage of Hepatocellular Carcinoma. Hepatology 69 (1), 196\u2013208 (2019).","journal-title":"Hepatology"},{"issue":"2","key":"57693_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41419-022-05406-3","volume":"14","author":"XJ Guo","year":"2023","unstructured":"Guo, X. J. et al. Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC\/PCAF\/AKT axis. Cell. Death Dis. 14 (2), 79 (2023).","journal-title":"Cell. Death Dis."},{"issue":"25","key":"57693_CR12","doi-asserted-by":"publisher","first-page":"22573","DOI":"10.1074\/jbc.M203009200","volume":"277","author":"J Bakker","year":"2002","unstructured":"Bakker, J., Lin, X. & Nelson, W. G. Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells. J. Biol. Chem. 277 (25), 22573\u201322580 (2002).","journal-title":"J. Biol. Chem."},{"issue":"12","key":"57693_CR13","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1016\/j.cgh.2020.08.065","volume":"19","author":"NP Chalasani","year":"2021","unstructured":"Chalasani, N. P. et al. A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma. Clin. Gastroenterol. Hepatol. 19 (12), 2597\u20132605 (2021). e2594.","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"57693_CR14","doi-asserted-by":"publisher","first-page":"1374465","DOI":"10.3389\/fimmu.2024.1374465","volume":"15","author":"S Xu","year":"2024","unstructured":"Xu, S. et al. A m(6)A regulators-related classifier for prognosis and tumor microenvironment characterization in hepatocellular carcinoma. Front. Immunol. 15, 1374465 (2024).","journal-title":"Front. Immunol."},{"issue":"12","key":"57693_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15 (12), 550 (2014).","journal-title":"Genome Biol."},{"issue":"1","key":"57693_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"43","key":"57693_CR17","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U S A. 102 (43), 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"57693_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"issue":"6","key":"57693_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell. Syst. 1 (6), 417\u2013425 (2015).","journal-title":"Cell. Syst."},{"key":"57693_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 9, 559 (2008).","journal-title":"BMC Bioinform."},{"issue":"1","key":"57693_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong, P. et al. Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. Cell. Rep. 18 (1), 248\u2013262 (2017).","journal-title":"Cell. Rep."},{"issue":"10","key":"57693_CR22","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/s41591-018-0157-9","volume":"24","author":"N Auslander","year":"2018","unstructured":"Auslander, N. et al. Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma. Nat. Med. 24 (10), 1545\u20131549 (2018).","journal-title":"Nat. Med."},{"issue":"11","key":"57693_CR23","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda, A., Lin, D. C., Assenov, Y., Plass, C. & Koeffler, H. P. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 28 (11), 1747\u20131756 (2018).","journal-title":"Genome Res."},{"key":"57693_CR24","doi-asserted-by":"crossref","unstructured":"Maeser, D., Gruener, R. F. & Huang, R. S. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform 22(6), 1\u20137 (2021).","DOI":"10.1093\/bib\/bbab260"},{"issue":"8","key":"57693_CR25","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos, A., Schrag, D., Raj, G. V. & Panageas, K. S. How to build and interpret a nomogram for cancer prognosis. J. Clin. Oncol. 26 (8), 1364\u20131370 (2008).","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"57693_CR26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/jama.2015.37","volume":"313","author":"M Fitzgerald","year":"2015","unstructured":"Fitzgerald, M., Saville, B. R. & Lewis, R. J. Decision curve analysis. JAMA 313 (4), 409\u2013410 (2015).","journal-title":"JAMA"},{"key":"57693_CR27","doi-asserted-by":"publisher","first-page":"620912","DOI":"10.3389\/fonc.2021.620912","volume":"11","author":"LM Li","year":"2021","unstructured":"Li, L. M. et al. Loss of TARBP2 Drives the Progression of Hepatocellular Carcinoma via miR-145-SERPINE1 Axis. Front. Oncol. 11, 620912 (2021).","journal-title":"Front. Oncol."},{"issue":"1","key":"57693_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen, D. S. & Mellman, I. Oncology meets immunology: the cancer-immunity cycle. Immunity 39 (1), 1\u201310 (2013).","journal-title":"Immunity"},{"issue":"23","key":"57693_CR29","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.1158\/0008-5472.CAN-18-0689","volume":"78","author":"L Xu","year":"2018","unstructured":"Xu, L. et al. TIP: A Web Server for Resolving Tumor Immunophenotype Profiling. Cancer Res. 78 (23), 6575\u20136580 (2018).","journal-title":"Cancer Res."},{"key":"57693_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.placenta.2023.05.001","volume":"138","author":"Y Zhou","year":"2023","unstructured":"Zhou, Y. et al. DNMT1 mediates proliferation, migration and invasion of extravillous trophoblasts by regulating the methylation level of APLNR. Placenta 138, 33\u201343 (2023).","journal-title":"Placenta"},{"issue":"3","key":"57693_CR31","doi-asserted-by":"publisher","first-page":"98703","DOI":"10.4251\/wjgo.v17.i3.98703","volume":"17","author":"H Xie","year":"2025","unstructured":"Xie, H. et al. DNMT1 promotes the proliferation and migration of gastric cancer cells by inducing microRNA-125a-5p methylation to promote SERPINE1 protein. World J. Gastrointest. Oncol. 17 (3), 98703 (2025).","journal-title":"World J. Gastrointest. Oncol."},{"issue":"4","key":"57693_CR32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/ijc.11127","volume":"105","author":"Y Saito","year":"2003","unstructured":"Saito, Y. et al. Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int. J. Cancer. 105 (4), 527\u2013532 (2003).","journal-title":"Int. J. Cancer"},{"issue":"1","key":"57693_CR33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12885-018-4056-8","volume":"18","author":"Z Liu","year":"2018","unstructured":"Liu, Z. et al. MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S\/G2 cell cycle progression. BMC Cancer. 18 (1), 200 (2018).","journal-title":"BMC Cancer"},{"issue":"10","key":"57693_CR34","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s41419-020-03039-y","volume":"11","author":"G Dong","year":"2020","unstructured":"Dong, G. et al. SPATS2, negatively regulated by miR-145-5p, promotes hepatocellular carcinoma progression through regulating cell cycle. Cell. Death Dis. 11 (10), 837 (2020).","journal-title":"Cell. Death Dis."},{"issue":"1","key":"57693_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12876-022-02633-y","volume":"23","author":"J Lin","year":"2023","unstructured":"Lin, J., Yan, J., Deng, X. L., Wang, C. S. & Wang, H. S. SPATS2 is correlated with cell cycle progression and immune cells infiltration in hepatocellular carcinoma. BMC Gastroenterol. 23 (1), 8 (2023).","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"57693_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-025-01732-z","volume":"18","author":"S Sun","year":"2025","unstructured":"Sun, S. et al. The role of neoantigens and tumor mutational burden in cancer immunotherapy: advances, mechanisms, and perspectives. J. Hematol. Oncol. 18 (1), 84 (2025).","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"57693_CR37","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.annonc.2024.03.007","volume":"35","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Tumor mutational burden for the prediction of PD-(L)1 blockade efficacy in cancer: challenges and opportunities. Ann. Oncol. 35 (6), 508\u2013522 (2024).","journal-title":"Ann. Oncol."},{"issue":"7","key":"57693_CR38","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1158\/1078-0432.CCR-18-3778","volume":"25","author":"R Pinyol","year":"2019","unstructured":"Pinyol, R., Sia, D. & Llovet, J. M. Immune Exclusion-Wnt\/CTNNB1 Class Predicts Resistance to Immunotherapies in HCC. Clin. Cancer Res. 25 (7), 2021\u20132023 (2019).","journal-title":"Clin. Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57693-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57693-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57693-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:01:55Z","timestamp":1783731715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57693-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57693"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57693-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"2 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The processing of clinical tissue samples is in strict compliance with the ethical standards of the Declaration of Helsinki. The present study was approved by the ethics committee of Yichang Central People\u2019s Hospital. Written informed consent was obtained from all the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"21629"}}